I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 25% ± 9% | |
| B cell | 9 studies | 18% ± 2% | |
| naive B cell | 6 studies | 19% ± 3% | |
| microglial cell | 5 studies | 25% ± 6% | |
| epithelial cell | 5 studies | 30% ± 10% | |
| astrocyte | 5 studies | 27% ± 8% | |
| natural killer cell | 5 studies | 18% ± 2% | |
| macrophage | 5 studies | 24% ± 6% | |
| oligodendrocyte precursor cell | 4 studies | 27% ± 9% | |
| endothelial cell of lymphatic vessel | 4 studies | 20% ± 4% | |
| oligodendrocyte | 4 studies | 25% ± 5% | |
| plasmacytoid dendritic cell | 4 studies | 19% ± 1% | |
| memory B cell | 4 studies | 17% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 3% | |
| non-classical monocyte | 3 studies | 25% ± 5% | |
| precursor B cell | 3 studies | 19% ± 0% | |
| immature B cell | 3 studies | 20% ± 0% | |
| GABAergic neuron | 3 studies | 43% ± 3% | |
| glutamatergic neuron | 3 studies | 52% ± 5% | |
| abnormal cell | 3 studies | 26% ± 8% | |
| fibroblast | 3 studies | 19% ± 4% | |
| transit amplifying cell | 3 studies | 29% ± 18% | |
| neuron | 3 studies | 23% ± 7% |
